Exane Derivatives’s Wabtec WAB Stock Holding History
Bought
Maintained
Sold
Other funds holding WAB
FCM
Exane Derivatives's WAB Position: Q2 2022 in Review
Exane Derivatives sold out of Wabtec (WAB) in Q2 2022, closing a stake of 62 shares — an estimated $5.96K sold.
Exane Derivatives first reported a position in WAB in Q4 2014 and held it in 26 quarters. The position peaked at $215K in Q4 2014. 766 funds tracked by Wall St. Rank hold WAB as of Q2 2022.
- Exane Derivatives reported no remaining Wabtec position as of Q2 2022 after selling out during the quarter.
- Exane Derivatives sold 62 Wabtec shares in Q2 2022, an estimated $5.96K.
- Exane Derivatives first reported a position in Wabtec in Q4 2014 and held it in 26 quarters.
- Exane Derivatives's Wabtec position peaked at $215K in Q4 2014.
- 766 funds tracked by Wall St. Rank held Wabtec as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.